• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

SNYNF:US

109.0000 USD 3.2200 3.04%

As of 20:10:00 ET on 08/26/2014.

Snapshot for Sanofi (SNYNF)

Open: 109.0000 Day's Range: 109.0000 - 109.0000 Volume: 217
Previous Close: 105.7800 52wk Range: 94.1500 - 110.1250 1-Yr Rtn: +13.19%

Stock Chart for SNYNF

No chart data available.
  • SNYNF:US 109.0000
  • 1D
  • 1M
  • 1Y
105.7800
Interactive SNYNF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNYNF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 15.9156
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 5.1970
Est. PEG Ratio 2.2260
Market Cap (M USD) 144,032.68
Shares Outstanding (M) 1,321.40
30 Day Average Volume 4,763
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.53%
Cash Dividend (EUR) 2.8000
Dividend Ex-Date 05/12/2014
5 Year Dividend Growth 6.02%
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNYNF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for SNYNF

Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

Serge Daniel WeinbergChairmanChristopher A Viehbacher "Chris"Chief Executive Officer
Anne C BealChief Patient OfficerElias A ZerhouniPres:Global Research & Dev
More Company Profile & Key Executives for SNYNF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil